Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.

President Xi plans to meet with Qualcomm and Saudi Aramco CEOs following this year’s China Development Forum, according to ...

After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...

Lane. Pfizer has deemed the property surplus and has offered to sell it to the city for $1.00. It is recommended that City ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

Alphabet's Google launched an experimental version of its search engine on Wednesday that completely eliminates its classic ...

The Irish economy is particularly vulnerable to US tariffs against the EU, as it exports relatively more to the US compared ...

Welcome back to our Sunday edition, where we round up some of our top stories and take you inside our newsroom. Jade Bonacolta landed five promotions at LinkedIn in less than seven years. The ...